SCHEMBL20629109

SCHEMBL20629109

CNC(O)C1CN(C(=O)OC(C)(C)C)C(Cc2ccc(Cl)cc2)CO1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.38
▸ CHIT1 Q13231 6/20 0.36
▸ CHIA Q9BZP6 4/20 0.36
▸ HTT P42858 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ STS P08842 2/20 0.36
▸ NR1D1 P20393 1/20 0.36
▸ CHI3L1 P36222 2/20 0.35
▸ P2RX3 P56373 3/20 0.35
▸ NR1H2 P55055 2/20 0.35
▸ NR1H3 Q13133 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28686316 0.89 CHIT1 (0.38) ATMCHIT1CHIAHTTSMN1; SMN2
SCHEMBL26438873 0.89 CHIT1 (0.38) ATMCHIT1CHIAHTTSMN1; SMN2
SCHEMBL22903686 0.89 CHIT1 (0.38) ATMCHIT1CHIAHTTSMN1; SMN2
SCHEMBL26438642 0.87 ATM (0.38) ATMCHIT1CHIAHTTSMN1; SMN2
SCHEMBL22903581 0.86 KCNH2 (0.47) ATMCHIT1CHIAHTTSMN1; SMN2
SCHEMBL28700089 0.86 KCNH2 (0.47) ATMCHIT1CHIAHTTSMN1; SMN2
SCHEMBL26438837 0.86 KCNH2 (0.47) ATMCHIT1CHIAHTTSMN1; SMN2
SCHEMBL28686358 0.86 CHIT1 (0.37) ATMCHIT1CHIAHTTSMN1; SMN2
SCHEMBL26438893 0.86 CHIT1 (0.37) ATMCHIT1CHIAHTTSMN1; SMN2
SCHEMBL18607749 0.84 CHIT1 (0.48) ATMCHIT1CHIAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3344616-B1 SUBSTITUTED AMINO TRIAZOLES USEFUL AS HUMAN CHITINASE INHIBITORS ONCOARENDI THERAPEUTICS SA (PL) 2019-01-09 — — EP disclosed
Send feedback